ATLASPrime Medicine (PRME) earnings date: Nov 6, 2026
Prime Medicine (PRME) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 6, 2026, before the open. Analysts expect EPS of -$0.23.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on PRME
| Last price | $4.72 (-9.9%) |
|---|---|
| Normal 1-day range (±1σ) | ±7.7% |
| Earnings beat history | Beat the EPS estimate in 4 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Prime Medicine stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Prime Medicine reports on Nov 6, 2026. One email the day before, with ATLAS’s read on Prime Medicine. You can switch it off at any time.
Alert me before PRME reportsFree to start. Creating an account takes under a minute.
PRME earnings at a glance
| Next report (confirmed) | Fri, Nov 6, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$0.23 |
| Last report | Aug 6, 2026 · Beat |
| Beat rate (last 5 reports) | 4 of 5 (80%) |
| Average EPS surprise | +4.8% |
| Average move around a report | ±9.0% (last 5) |
| Sector | Healthcare · Biotechnology |
Prime Medicine earnings history: last 5 reports
Prime Medicine last reported on Aug 6, 2026: EPS of -$0.24 against an estimate of -$0.26 (+7.7% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 6, 2026 | -$0.26 | -$0.24 | +7.7% | Beat | 0.0% |
| Jul 10, 2026 | $1.49 | $1.56 | +4.7% | Beat | -16.9% |
| May 7, 2026 | -$0.25 | -$0.28 | -12.0% | Miss | -5.9% |
| Mar 3, 2026 | -$0.26 | -$0.24 | +7.7% | Beat | -11.6% |
| Jan 23, 2026 | $1.61 | $1.87 | +16.2% | Beat | -10.6% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for PRME
See the fair value, the probability range and the earnings history of Prime Medicine on its ATLAS page.
Prime Medicine (PRME) stock analysisPlans from €3.99 a month.
Prime Medicine earnings: frequently asked questions
When does Prime Medicine (PRME) report earnings?
Prime Medicine is scheduled to report on Friday, November 6, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for PRME?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$0.23 per share (USD). Estimates can change before the report.
How often does PRME beat earnings estimates?
Of its last 5 reports with a recorded result, Prime Medicine beat the EPS estimate 4 times; the average surprise was +4.8%. Past results do not predict the next one.
How much does PRME move around earnings?
Over its last 5 reports the stock moved an average of 9.0% (absolute, from the close before the report day to the close after it), and finished higher 0 of 5 times.
Did Prime Medicine beat earnings estimates last quarter?
Prime Medicine last reported on Aug 6, 2026: EPS of -$0.24 against an estimate of -$0.26 (+7.7% surprise), a beat.
How much does PRME usually move in a day?
On a normal trading day the ATLAS model puts PRME’s one-day range at about ±7.7%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 6, 2026
Educational information, not investment advice. Disclaimer